392 related articles for article (PubMed ID: 26435415)
21. Polycystin-1 maturation requires polycystin-2 in a dose-dependent manner.
Gainullin VG; Hopp K; Ward CJ; Hommerding CJ; Harris PC
J Clin Invest; 2015 Feb; 125(2):607-20. PubMed ID: 25574838
[TBL] [Abstract][Full Text] [Related]
22. Triptolide reduces cyst formation in a neonatal to adult transition Pkd1 model of ADPKD.
Leuenroth SJ; Bencivenga N; Chahboune H; Hyder F; Crews CM
Nephrol Dial Transplant; 2010 Jul; 25(7):2187-94. PubMed ID: 20139063
[TBL] [Abstract][Full Text] [Related]
23. Progressive development of polycystic kidney disease in the mouse model expressing Pkd1 extracellular domain.
Kurbegovic A; Trudel M
Hum Mol Genet; 2013 Jun; 22(12):2361-75. PubMed ID: 23439951
[TBL] [Abstract][Full Text] [Related]
24. VEGF receptor inhibition blocks liver cyst growth in pkd2(WS25/-) mice.
Amura CR; Brodsky KS; Groff R; Gattone VH; Voelkel NF; Doctor RB
Am J Physiol Cell Physiol; 2007 Jul; 293(1):C419-28. PubMed ID: 17475663
[TBL] [Abstract][Full Text] [Related]
25. Inhibiting the HSP90 chaperone slows cyst growth in a mouse model of autosomal dominant polycystic kidney disease.
Seeger-Nukpezah T; Proia DA; Egleston BL; Nikonova AS; Kent T; Cai KQ; Hensley HH; Ying W; Chimmanamada D; Serebriiskii IG; Golemis EA
Proc Natl Acad Sci U S A; 2013 Jul; 110(31):12786-91. PubMed ID: 23858461
[TBL] [Abstract][Full Text] [Related]
26. Cardiac defects and renal failure in mice with targeted mutations in Pkd2.
Wu G; Markowitz GS; Li L; D'Agati VD; Factor SM; Geng L; Tibara S; Tuchman J; Cai Y; Park JH; van Adelsberg J; Hou H; Kucherlapati R; Edelmann W; Somlo S
Nat Genet; 2000 Jan; 24(1):75-8. PubMed ID: 10615132
[TBL] [Abstract][Full Text] [Related]
27. Double inhibition of cAMP and mTOR signalling may potentiate the reduction of cell growth in ADPKD cells.
de Stephanis L; Bonon A; Varani K; Lanza G; Gafà R; Pinton P; Pema M; Somlo S; Boletta A; Aguiari G
Clin Exp Nephrol; 2017 Apr; 21(2):203-211. PubMed ID: 27278932
[TBL] [Abstract][Full Text] [Related]
28. Molecular genetics and mechanism of autosomal dominant polycystic kidney disease.
Wu G; Somlo S
Mol Genet Metab; 2000 Jan; 69(1):1-15. PubMed ID: 10655152
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of Hedgehog signaling suppresses proliferation and microcyst formation of human Autosomal Dominant Polycystic Kidney Disease cells.
Silva LM; Jacobs DT; Allard BA; Fields TA; Sharma M; Wallace DP; Tran PV
Sci Rep; 2018 Mar; 8(1):4985. PubMed ID: 29563577
[TBL] [Abstract][Full Text] [Related]
30. Genetic Mechanisms of ADPKD.
Kim DY; Park JH
Adv Exp Med Biol; 2016; 933():13-22. PubMed ID: 27730431
[TBL] [Abstract][Full Text] [Related]
31. Nonselective Cyclooxygenase Inhibition Retards Cyst Progression in a Murine Model of Autosomal Dominant Polycystic Kidney Disease.
Zhang M; Srichai MB; Zhao M; Chen J; Davis LS; Wu G; Breyer MD; Hao CM
Int J Med Sci; 2019; 16(1):180-188. PubMed ID: 30662341
[No Abstract] [Full Text] [Related]
32. Association of PKD2 (polycystin 2) mutations with left-right laterality defects.
Bataille S; Demoulin N; Devuyst O; Audrézet MP; Dahan K; Godin M; Fontès M; Pirson Y; Burtey S
Am J Kidney Dis; 2011 Sep; 58(3):456-60. PubMed ID: 21719175
[TBL] [Abstract][Full Text] [Related]
33. Mitochondrial Abnormality Facilitates Cyst Formation in Autosomal Dominant Polycystic Kidney Disease.
Ishimoto Y; Inagi R; Yoshihara D; Kugita M; Nagao S; Shimizu A; Takeda N; Wake M; Honda K; Zhou J; Nangaku M
Mol Cell Biol; 2017 Dec; 37(24):. PubMed ID: 28993480
[TBL] [Abstract][Full Text] [Related]
34. Adenylyl cyclase 5 deficiency reduces renal cyclic AMP and cyst growth in an orthologous mouse model of polycystic kidney disease.
Wang Q; Cobo-Stark P; Patel V; Somlo S; Han PL; Igarashi P
Kidney Int; 2018 Feb; 93(2):403-415. PubMed ID: 29042084
[TBL] [Abstract][Full Text] [Related]
35. Neonatal onset autosomal dominant polycystic kidney disease (ADPKD) in a patient homozygous for a PKD2 missense mutation due to uniparental disomy.
Losekoot M; Ruivenkamp CA; Tholens AP; Grimbergen JE; Vijfhuizen L; Vermeer S; Dijkman HB; Cornelissen EA; Bongers EM; Peters DJ
J Med Genet; 2012 Jan; 49(1):37-40. PubMed ID: 22114106
[TBL] [Abstract][Full Text] [Related]
36. Identification of ADPKD-Related Genes and Pathways in Cells Overexpressing
Zhang Z; Dang Y; Wang Z; Wang H; Pan Y; He J
Genes (Basel); 2020 Jan; 11(2):. PubMed ID: 31979107
[TBL] [Abstract][Full Text] [Related]
37. Aberrant PKD2 splicing due to a presumed novel missense mutation in autosomal-dominant polycystic kidney disease.
Tan YC; Blumenfeld J; Michaeel A; Donahue S; Balina M; Parker T; Levine D; Rennert H
Clin Genet; 2011 Sep; 80(3):287-92. PubMed ID: 20950398
[TBL] [Abstract][Full Text] [Related]
38. PKD2-Related Autosomal Dominant Polycystic Kidney Disease: Prevalence, Clinical Presentation, Mutation Spectrum, and Prognosis.
Cornec-Le Gall E; Audrézet MP; Renaudineau E; Hourmant M; Charasse C; Michez E; Frouget T; Vigneau C; Dantal J; Siohan P; Longuet H; Gatault P; Ecotière L; Bridoux F; Mandart L; Hanrotel-Saliou C; Stanescu C; Depraetre P; Gie S; Massad M; Kersalé A; Séret G; Augusto JF; Saliou P; Maestri S; Chen JM; Harris PC; Férec C; Le Meur Y
Am J Kidney Dis; 2017 Oct; 70(4):476-485. PubMed ID: 28356211
[TBL] [Abstract][Full Text] [Related]
39. Novel PKD1 and PKD2 mutations in autosomal dominant polycystic kidney disease (ADPKD).
Hoefele J; Mayer K; Scholz M; Klein HG
Nephrol Dial Transplant; 2011 Jul; 26(7):2181-8. PubMed ID: 21115670
[TBL] [Abstract][Full Text] [Related]
40. Identification of pathological transcription in autosomal dominant polycystic kidney disease epithelia.
Friedrich S; Müller H; Riesterer C; Schüller H; Friedrich K; Wörner CL; Busch T; Viau A; Kuehn EW; Köttgen M; Hofherr A
Sci Rep; 2021 Jul; 11(1):15139. PubMed ID: 34301992
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
